Standard BioTools

是其中之一......

• Russell 3000;
• TOB Iconic 10,000.

Standard BioTools 是一家在股票代码 FLDM (US) 下上市的公司。

他们在：

• 医疗设备50%
• 生物技术50%

涉及Standard BioTools的并购和融资。

• Standard BioTools and SomaLogic have merged  (公布2024一月5号)..
• SomaLogic and Standard BioTools have announced they will merge  (公布2023十月6号)..

查看带有其 24 名主要高管的组织结构图

Standard BioTools 搜索最多的简介

• Michael Egholm, Chief Executive Officer and President
• Tom Carey, Chairman of the Board
• Fenel Eloi, Director

高管在Standard BioTools变化

• Jonathan Mickelsen 曾任 Vice President, Corporate Controller, 将于 202411月11 升职为 Vice President and Chief Accounting Officer  (新闻发布的2024十一月8号).
• Alex Kim 曾任 Chief Operating Officer and Interim Chief Financial Officer, 将于 202411月11 现任 Chief Financial Officer  (新闻发布的2024十一月8号).
• Alex Kim 曾任 Chief Operating Officer, 将于 20249月1 升职为 Chief Operating Officer and Interim Chief Financial Officer  (新闻发布的2024八月1号).

更多的变化在％s

创建提醒
跟踪 Standard BioTools 的高管变动

Standard BioTools 拥有 1,005 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。

Popular M&A news in 医疗设备

• Precision Neuroscience 刚刚宣布为 102 筹款数百万美元。 (公布2024十二月18号).
• electroCore 已收购 NeuroMetrix (公布2024十二月18号).
• Anteris Technologies 刚刚宣布为 89 筹款数百万美元。 (公布2024十二月16号).

医疗设备 行业的其他推荐联系人

• Medical Microinstruments 企业 Andrew Elbardissi - Director
• Thermo Fisher Scientific 企业 Marc Casper - Chairman of the Board, President and Chief Executive Officer
• Illumina 企业 Frances Arnold - Director

了解更多有关医疗设备行业的信息 >

Standard BioTools 的最新新闻稿

• Standard BioTools Announces Conference Call and Webcast of Second Quarter 2022 Financial Results | Standard BioTools Inc.
• Press Releases | Standard BioTools Inc.
• Standard BioTools Announces First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Announces Conference Call and Webcast of First Quarter 2022 Financial Results | Fluidigm Corporation
• Standard BioTools Launches Hyperion+ Imaging System, the New Standard in High-Plex Spatial Imaging | Fluidigm Corporation
• Standard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Fluidigm Corporation
• Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. | Fluidigm Corporation
• Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion | Fluidigm Corporation
• Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global | Fluidigm Corporation
• Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution | Fluidigm Corporation
• View more press releases Close

关于 Standard BioTools 的社交媒体

• Standard BioTools 在 维基百科、谷歌新闻 和 雅虎财经
• Standard BioTools 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Michael Egholm

致电Standard BioTools，电话：+1 650...

查看组织结构图

Register to receive your alert

报告错误